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Abstract
Background: Excessive developmental failure occurs during the first week of in vitro embryo
development due to elevated levels of cell death and arrest. We hypothesize that permanently
arrested embryos enter a stress-induced "senescence-like" state that is dependent on the oxidative
stress-adaptor and lifespan determinant protein p66Shc. The aim of this study was to selectively
diminish p66Shc gene expression in bovine oocytes and embryos using post-transcriptional gene
silencing by RNA-mediated interference to study the effects of p66Shc knockdown on in vitro
fertilized bovine embryos.
Results: Approximately 12,000–24,000 short hairpin (sh)RNAi molecules specific for p66Shc were
microinjected into bovine germinal vesicle stage oocytes or zygotes. Experiments were comprised
of a control group undergoing IVF alone and two groups microinjected with and without p66Shc
shRNAi molecules prior to IVF. The amount of p66Shc mRNA quantified by Real Time PCR was
significantly (P < 0.001) lowered upon p66Shc shRNAi microinjection. This reduction was selective
for p66Shc mRNA, as both histone H2a and p53 mRNA levels were not altered. The relative signal
strength of p66Shc immuno-fluorescence revealed a significant reduction in the number of pixels
for p66Shc shRNAi microinjected groups compared to controls (P < 0.05). A significant decrease
(P < 0.001) in the incidence of arrested embryos upon p66Shc shRNAi microinjection was detected
compared to IVF and microinjected controls along with significant reductions (P < 0.001) in both
cleavage divisions and blastocyst development. No significant differences in p66Shc mRNA levels (P
= 0.314) were observed among the three groups at the blastocyst stage.
Conclusion: These results show that p66Shc is involved in the regulation of embryo development
specifically in mediating early cleavage arrest and facilitating development to the blastocyst stage for
in vitro produced bovine embryos.
Background
One feature of in vitro produced mammalian embryos is
the high frequency of early developmental failure brought
on by sub-optimal culture environments [1-3]. Fewer
than half of all in vitro fertilized (IVF) bovine embryos
reach the blastocyst stage of development [4] with many
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of these unable to sustain development following embryo
transfer [5]. The reasons for this high rate of in vitro
embryo demise remains unclear, but it has been proposed
as a protective mechanism for preventing further develop-
ment of abnormal, poor quality embryos. Almost half of
all arrested human embryos display chromosomal abnor-
malities [6], and significantly more chromosomal aberra-
tions are observed, alongside delayed development, for in
vitro produced bovine embryos compared to their in vivo-
derived counterparts [7,8]. Blastomeres with characteristic
features of apoptosis, such as cytoplasmic, nuclear and
DNA fragmentation, have been detected in both in vitro
and in vivo derived embryos, indicating that high levels of
apoptosis might play a role in early embryo death [9,10].
In situ TUNEL labelling has identified a greater incidence
of apoptotic nuclei in cultured bovine blastocysts com-
pared to those derived in vivo [11]. Interestingly, we
[1,12,13] and others [11,14] have observed no morpho-
logical or biochemical signs of apoptosis during the early
2–4 cell cleavage stages of bovine embryogenesis. It is at
this early developmental stage that approximately 14% of
all in vitro produced (IVP) bovine embryos permanently
arrest in a senescence-like state (Fig. 1) [2,15].
Cellular or replicative senescence is the well known in vitro
phenomenon whereby most proliferating somatic cell
types irreversibly cease in their replicative capacity after a
fixed number of population doublings and display dis-
tinct morphological features of "aged" cells [16,17].
Senescence is triggered by a p53-dependent signalling cas-
cade associated with the shortening of telomeres, the tan-
dem G-rich repetitive, non-coding DNA sequences and
specific binding proteins at the ends of linear chromo-
somes [18-21]. We have previously shown that perma-
nent cell growth arrest of cultured bovine somatic cells is
associated with telomere shortening [22], increased levels
of serine 20-p53 phosphorylation, and elevated levels of
oxidative damage [23]. Since permanent growth arrest/
cellular senescence occurs prematurely under conditions
of elevated oxidative stress [24,25] and can be activated by
disruption of the telomere structure itself, even at maxi-
mally long telomere lengths [26,27], we hypothesize that
arrested mammalian embryos permanently arrest in their
development by a similar stress signalling pathway.
At the cellular level, an oxidative stress sensor that can
provide a key understanding of cell senescence and per-
manent embryo arrest is p66Shc, the recently identified
protein belonging to the Shc family of adaptors for signal
transduction in mitogenic and apoptotic responses.
p66Shc is involved in signal transduction pathways that
regulate the cellular response to oxidative stress and life
span and has been shown to act as a downstream target of
p53-mediated elevation of intracellular oxidants, cyto-
chrome c release and apoptosis [28,29]. p66Shc is impor-
tant in the signalling response to ROS and propagation of
apoptotic signals in mouse fibroblasts [30,31]. Remarka-
bly, p66Shc(-/-) mice exhibit increased resistance to oxi-
dative stress and have a ~30% longer lifespan than wild-
type control animals with no apparent side effects [32].
We have measured elevated levels of p66Shc mRNA and
protein in senescent somatic cells and in permanently
arrested 2–4 cell bovine embryos [2,23]. Recently, we
have demonstrated that p66Shc is significantly more
abundant in an embryo population that exhibits higher
frequencies of embryo arrest and quantities of intracellu-
lar ROS [15]. Taken together, these data suggests that
p66Shc regulates an oxidative stress-induced senescence
pathway that triggers permanent embryo arrest. The objec-
tive of this study was to elucidate a functional role for
p66Shc in embryo arrest by selectively decreasing p66Shc
levels in bovine oocytes and embryos using the post-tran-
scriptional gene silencing technique of RNA interference
(RNAi).
Results
Quantification of p66Shc, H2a and p53 mRNA transcripts
Determination of the number of p66Shc, H2a and p53
mRNA transcripts was carried out by Real Time PCR in
arrested 2–4 cell embryos collected at day 8 post-insemi-
nation, in early cleaving embryos (28 hours post insemi-
nation (hpi)) that show very low percentage of embryo
arrest and in late cleaving embryos (29 to 48 hpi) that are
more likely to arrest, in accordance to previous observa-
tions [2]. These data are summarized in Table 1 along
Appearance of 2–4 cell arrested embryos at day-8 post  insemination Figure 1
Appearance of 2–4 cell arrested embryos at day-8 post 
insemination. Morphological appearance of day-8 in vitro pro-
duced bovine embryos. Embryos at this time after in vitro fer-
tilization usually reached the blastocyst stage (a), while 
arrested embryos still appeared as morphologically normal 
2–4 cell embryos (b). (Magnification: 400×).BMC Developmental Biology 2007, 7:132 http://www.biomedcentral.com/1471-213X/7/132
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with the amounts of these specific gene transcripts in day
8 blastocysts. Significantly greater quantities of p66Shc
mRNA transcripts (2.3–3.4 fold greater) were measured in
both arrested (P < 0.0001) and late cleaving embryos (P <
0.005) that are more likely to arrest compared to early
cleaving 28 hpi embryos. No differences in H2a or p53
mRNA levels were detected among early and late cleaving
embryos, arrested embryos, and blastocysts. The numbers
of p66Shc mRNA transcripts at the blastocyst stage were
significantly (P < 0.001) lowered compared to those
measured in early cleaving and arrested embryos (Table
1).
Determination of the number of p66Shc shRNAi molecules 
to microinject
In the attempt to down-regulate p66Shc mRNA expres-
sion, we wanted to microinject the amount of p66Shc
hairpin RNAi molecules equivalent to the number of cop-
ies of p66Shc transcripts measured in arrested 2–4 cell
embryos. The average amount of p66Shc mRNA tran-
scripts in arrested 2–4 cell embryos, as detected by Real
Time PCR, was 4.02 ± 0.1 × 10-5 pg/embryo (Table 1).
Using the size of the amplified PCR fragment (336 bp)
and the molecular weight of the nucleotides, the quantity
(pg) of p66Shc mRNA in arrested 2–4 cell embryos were
transformed to equivalent numbers of p66Shc mRNA
transcripts of approximately 11,800 ± 600. Therefore,
approximately 12,000 p66Shc short hairpin RNAi mole-
cules were microinjected in the subsequent experiments.
To further verify a dose-dependent silencing/reduction of
p66Shc protein levels we also injected twice (~24,000
molecules) the amount of p66Shc shRNAi molecules.
Successful selective down-regulation of p66Shc
To assess whether p66Shc expression was selectively
down-regulated by the injection of approximately 12,000
and 24,000 p66Shc short hairpin RNAi molecules, we
quantified p66Shc mRNA and protein levels in 35 hpi
embryos by Real Time PCR and by quantitative immuno-
florescence, respectively. The IVF control group contained
0.92 ± 0.02 × 10-5 pg of p66Shc mRNA, the vehicle alone
microinjected group 1.2 ± 0.2 × 10-5 and the p66Shc shR-
NAi microinjected group 0.46 ± 0.06 × 10-5 pg of p66Shc
transcripts (Fig. 2A). Therefore, this result demonstrated
that microinjection of oocytes at the GV stage with the
p66Shc shRNAi molecule resulted in significantly lower
levels of p66Shc mRNA (P ≤ 0.001) by 54% attained in
comparison to the control and vehicle microinjected
groups. To confirm that the down-regulation was selective
towards p66Shc mRNA, p66Shc shRNAi treatment did
not significantly affect (P = 0.744) the mRNA levels of the
housekeeping gene histone H2a in the three groups con-
sidered (Fig. 2B). In addition, Real Time PCR evaluation
of the p53 mRNA levels following p66Shc down-regula-
tion was also performed obtaining no significant differ-
ences (P = 0.98) in p53 mRNA transcript abundance
among the control, vehicle microinjected and p66Shc
shRNAi molecule microinjected groups (Fig. 2C).
The p66Shc protein levels and distribution patterns in
non-injected and vehicle microinjected groups were not
different, displaying relatively high immunofluorescence
intensities and punctate staining patterns in the cyto-
plasm and nuclei of all embryos analyzed (Fig. 3A,B).
Unexpectedly, a peri-nuclear ring of staining around the
nuclei was readily apparent (Fig. 3A,B). In contrast, 35 hpi
embryos that had been injected with ~12,000 (Fig. 3C)
and ~24,000 (Fig. 3D) p66Shc shRNAi molecules showed
visible reductions in p66Shc fluorescence staining intensi-
ties. Control embryos treated with the secondary FITC-
conjugated antibody alone (no primary antisera) exhib-
ited virtually no staining (Fig. 3E). Quantitative analysis
of the relative signal strength of p66Shc fluorescence
revealed a significant (P < 0.05) reduction in pixel num-
bers for both low (12,000) and high (~24,000) p66 shR-
NAi microinjected groups compared to non-injected and
vehicle injected controls (Fig. 3F). The knockdown effi-
ciency of p66Shc protein was 52.5% for 12,000 shRNAi
molecules and 96.8% for 24,000 shRNAi molecules com-
pared to p66Shc levels in vehicle-injected embryos.
Table 1: Quantity of p66Shc, p53 and H2a mRNA transcripts in early cleaving, late cleaving, 2–4 cell arrested embryos and bovine 
blastocysts
Quantity of mRNA transcripts/embryo (pg)
Early cleaving embryos (28 hpi) Late cleaving embryos (29 to 48 hpi) 2–4 cell arrested embryos Blastocysts
p66Shc 1.20 ± 0.30 × 10-5 a 2.80 ± 0.32 × 10-5 b 4.02 ± 0.21 × 10-5 c 0.50 ± 0.07 × 10-5 d
H2a 0.53 ± 0.09 × 10-3 a' 0.43 ± 0.12 × 10-3 a' 0.46 ± 0.13 × 10-3 a' 0.43 ± 0.13 × 10-3 a'
p53 0.95 ± 0.13 × 10-6 a" 1.01 ± 0.15 × 10-6 a" 0.81 ± 0.22 × 10-6 a" 1.70 ± 0.50 × 10-6 a"
Values represent mean ± SEM
Different superscripts differ significantly (a,bP < 0.005; a,cP < 0.0001; a,dP < 0.001)BMC Developmental Biology 2007, 7:132 http://www.biomedcentral.com/1471-213X/7/132
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Effects of p66Shc knockdown on in vitro embryo 
development
The percentage of embryo cleavage varied significantly
among the three groups with 84.1 ± 1.9% of oocytes
cleaved after fertilization in the control non-injected
group, 41.0 ± 2.4% in the group microinjected with only
the vehicle and 27.7 ± 3.2% when the p66Shc hairpin
RNAi molecules were microinjected (P < 0.001) (Fig. 4A).
The developmental frequencies to the blastocyst stage, cal-
culated as the number of blastocysts over the total number
of cleaved oocytes, was 29.8 ± 1.6%, 21.8 ± 0.5% and 8.7
± 1.4% for the control, vehicle and p66Shc RNAi microin-
jected groups respectively (P < 0.001) (Fig. 4B). Subse-
quent injections of scrambled short-interfering (si)RNA
control molecules, non-specific for any endogenous tran-
scripts, had no affect on embryo arrest frequencies and
developmental potential of bovine embryos compared to
vehicle-injected embryos (data not shown). Interestingly,
while there were no significant differences in the percent-
age of arrested 2–4 cell embryos between the control
(13.3 ± 0.8%) and the group microinjected with the vehi-
cle (10.8 ± 0.7%), there was a significant decrease (P <
0.001) in the percentage of permanent embryo arrest in
the group where p66Shc was down-regulated (Fig. 4C),
which showed only 0.9 ± 0.9% of cleaved embryos arrest-
ing. Assessment of spontaneous oocyte cleavage revealed
7.2 ± 0.7% oocytes spontaneously cleaved in the control
group, a significant decrease (P < 0.05) in spontaneous
cleaved oocytes after microinjection with 2.1 ± 2.1% in
the vehicle microinjected group, and no spontaneous
oocyte cleavage in the p66Shc microinjected group. The
differences in spontaneous oocyte cleavage between the
vehicle and p66Shc shRNAi injected groups were not sig-
nificant (P > 0.05) (Fig. 4D).
No differences in p66Shc transcript levels were detected in 
embryos that reached the blastocyst stage
Quantification by Real Time PCR of p66Shc mRNA in
blastocysts collected at day-9 post-insemination from the
three groups, showed no significant differences in p66Shc
mRNA levels (p = 0.314) among the different groups (Fig.
5A), with 0.59 ± 0.1 × 10-5 pg of p66Shc mRNA in the con-
trol group, 0.57 ± 0.2 × 10-5 pg in the vehicle microin-
jected group and 0.51 ± 0.2 × 10-5 pg in the p66Shc
shRNAi microinjected group. The amount of p66Shc tran-
scripts in each group reflects the amount normally
detected at the blastocyst stage (Table 1). Quantification
of the housekeeping gene, H2a, was used as a control and
showed no significant differences (p = 0.312) (Fig. 5B).
Discussion
The results presented here demonstrate the successful
application of RNA interference (RNAi) in selectively
diminishing the oxidative stress adaptor protein p66Shc
during in vitro bovine embryo development. Based on our
Real Time PCR quantification of p66Shc mRNA levels at the  2-cell stage following RNAi Figure 2
Real Time PCR quantification of p66Shc mRNA levels at the 
2-cell stage following RNAi. Real Time PCR analysis of 
p66Shc (A) and H2a (B) mRNA levels in 35 hpi embryos fol-
lowing control IVF, microinjection of the vehicle and microin-
jection with 12,000 p66Shc hairpin RNAi molecules. p66Shc 
mRNA levels decreased in p66Shc RNAi microinjected 
embryos (*P < 0.001), while Histone H2a mRNA levels 
showed no significant differences (P = 0.744) among the 
three groups. This result provided evidence that the down-
regulation of p66Shc mRNA levels following p66Shc hairpin 
RNAi molecule injection is selective for p66Shc transcripts. 
Real Time PCR analysis of p53 mRNA levels (C) for the 
three groups was also performed, showing no significant dif-
ferences (P = 0.98). The experiments were conducted on 
three different pools of 80–100 embryos (n = 3) and repli-
cated three times (r = 3) for each sample. The data were 
normalized for the content in one embryo.BMC Developmental Biology 2007, 7:132 http://www.biomedcentral.com/1471-213X/7/132
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p66Shc protein levels following microinjection of p66 shRNA interfering molecules Figure 3
p66Shc protein levels following microinjection of p66 shRNA interfering molecules. The distribution of p66Shc in early bovine 
embryos was assessed (A, B, C and D). Green, red and blue colors in each representative photomicrograph indicate positive 
staining for the respective primary antibody: p66Shc (FITC), F-actin (Rhodamine phalloidin), and nuclei (DAPI) respectively. 
Panels A and B represent Uninjected and Injected (Vehicle) controls respectively. Panel C (shRNAi low dose = ~12,000 mole-
cules) and Panel D (shRNA high dose = ~24,000 molecules) display a marked reduction in p66 fluorescence. Panel E represent 
the no primary antibody controls. Scion Image analysis resulted in the quantification of FITC immunofluorescence (p66Shc) 
across different groups (F). Relative signal strengths are presented as the mean ± S.E.M. representative of three independent 
replicates. Bars with different letters represent significant differences in relative signal strength between treatment groups (P ≤ 
0.05).BMC Developmental Biology 2007, 7:132 http://www.biomedcentral.com/1471-213X/7/132
Page 6 of 15
(page number not for citation purposes)
previous findings that showed significantly elevated levels
of p66Shc and reactive oxygen species in permanently
arrested 2–4 cell bovine embryos [2,15], the goal in this
study was to decrease p66Shc levels in developing bovine
oocytes and embryos to elucidate a functional role for
p66Shc in early embryo arrest. We significantly decreased
the number of p66Shc mRNA transcripts and protein by
approximately 54% by microinjecting ~12,000 short hair-
pin (sh)RNAi molecules specific for the bovine p66Shc
mRNA sequence into GV stage oocytes. Concomitant with
this reduction in p66Shc mRNA and protein levels, we
observed a significant reduction in permanently arrested
2–4 cell embryos of approximately 93%. Therefore, this
study clearly demonstrates a direct functional association
Real Time PCR quantification of p66Shc mRNA levels at the  blastocyst stage following RNAi Figure 5
Real Time PCR quantification of p66Shc mRNA levels at the 
blastocyst stage following RNAi. Real Time PCR analysis of 
p66Shc (A) and H2a (B) mRNA levels in day 8–9 blastocysts 
obtained following control IVF, microinjection of the vehicle 
and microinjection of 12,000 p66Shc short hairpin shRNAi 
molecules. No significant differences (P = 0.314) in the 
p66Shc mRNA levels were measured (A). The quantification 
of the histone H2a mRNA levels was used as a control, 
observing no significant differences (P = 0.312) (B). The 
experiments were conducted on three different pools of 80–
100 embryos (n = 3) and replicated three times (r = 3) for 
each sample. The data were normalized for the content in 
one blastocyst.
Assessment of cleavage, blastocyst, 2–4 cell embryo arrest  and spontaneous embryo cleavage rates following microin- jection with p66Shc hairpin RNAi molecules Figure 4
Assessment of cleavage, blastocyst, 2–4 cell embryo arrest 
and spontaneous embryo cleavage rates following microin-
jection with p66Shc hairpin RNAi molecules. Cleavage rate 
(A) and spontaneous cleavage rate (D) were evaluated at 
day-2 post insemination, while blastocyst rate (B) and arrest 
rate (C) were evaluated at day 8–9 post insemination. 
Although cleavage and blastocyst frequencies were signifi-
cantly decreased (P < 0.001) in the embryos microinjected 
with the vehicle alone, an even greater significant decrease (P 
< 0.001) was observed in the p66Shc shRNAi microinjected 
oocytes (A, B). We observed a significant decrease (P < 0.05) 
in spontaneous oocyte cleavage rate following microinjection 
(D). A significant decrease in the frequency of arrested 2–4 
cell embryos was achieved only following microinjection of 
short hairpin RNAi molecules against p66Shc (C). Bars with 
different letters represent significant differences between 
groups (P ≤ 0.05).BMC Developmental Biology 2007, 7:132 http://www.biomedcentral.com/1471-213X/7/132
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between high levels of p66Shc with early embryo arrest.
However, down-regulation of p66Shc also induced a sig-
nificant reduction in the number of cleaved embryos and
blastocysts signifying that it may play a vital role in facili-
tating early embryonic development as well.
Since permanent embryo arrest occurs before the major
activation of the embryonic genome [33-35], microinjec-
tion of the p66Shc hairpin RNAi molecules was required
at the germinal vesicle (GV) stage to maximize the effects
of RNAi mediated reduction of endogenous p66Shc tran-
scripts. Microinjection was carried out on cumulus-intact
GV oocytes, but this presented several challenges. Accord-
ingly, care was taken to minimize the damage to COCs by
the holding pipette, which readily stripped off the cumu-
lus cells, and to reduce oocyte injury by the injection
pipette since the ooplasm contents were not easily visible
and piercing of the GV was possible (Fig. 6). Denuded
immature oocytes do exhibit a decreased ability to reach
the second metaphase (MII stage), with a greater inci-
dence of abnormal fertilization, reduced pronuclei forma-
tion, and reduced cleavage and blastocyst development
[36-39]. When we microinjected embryos without the
p66Shc shRNAi molecules (vehicle control), we found a
significant decrease in these parameters with 41.0 ± 2.4%
of embryos cleaved, 21.8 ± 0.5% of embryos that develop
to the blastocyst stage and 10.8 ± 0.7% of embryos that
arrested. It appears that the micromanipulation procedure
itself affects the developmental potential of IVP bovine
embryos reaching the blastocyst stage in vitro. A similar
decrease in cleavage and blastocyst rates has been reported
after pronuclear injection of bovine zygotes [40]. To
improve oocyte survival following microinjection of RNAi
molecules the use of cytochalasin B and cycloheximide
treatment prior to puncture have improved oocyte sur-
vival rates to levels comparable to non-punctured control
oocytes [41].
Only a limited number of studies have been carried out
using RNA interference in mammalian oocytes and
embryos [41-46]. Svoboda et al. (2000) were able to
down-regulate the expression of specific target genes up to
80% in a dose-dependent manner. They microinjected
short hairpin RNAi molecules in mouse oocytes, obtain-
ing a viable down-regulation using a range between 1.0 ×
104 and 1.5 × 106 molecules in a volume of 5 pl [47].
Wianny and Zernicka-Goetz (2000) microinjected mouse
oocytes with 0.1 to 2.0 µg/µl of hairpin RNAi molecules
in a larger volume, up to 10 pl, to down-regulate their
genes of interest. Marked success was also achieved by
microinjection of the short interfering siRNA expression
vector directly into the nuclei of 2-cell mouse embryos in
a concentration of 10 ng/µl [46]. In the present study,
approximately 12,000 p66Shc hairpin RNAi molecules
were microinjected in GV-stage bovine oocytes, represent-
ing the number of p66Shc mRNA molecules previously
quantified in arrested 2-cell embryos [2]. The microinjec-
tion volume we utilized needed to be significantly smaller
than what was used previously for mouse oocytes. Micro-
injection of a volume greater than 0.25 pl resulted in
mechanical lysis of the GV bovine oocytes. This species-
difference might be due to a greater fragility of bovine
oocytes versus mouse oocytes or to different parameters,
such as the optimal pressure utilized for the microinjec-
tion and the microinjection needle diameter.
Early cleaving co-culture embryos known to display high
developmental potential and a low incidence of embryo
arrest [2], exhibit an average p66Shc mRNA concentration
of 1.20 ± 0.30 × 10-5 pg per embryo, while late cleaving
embryos, which are significantly more likely to arrest,
contain a p66Shc mRNA amount of over twice as much
(2.80 ± 0.32 × 10-5 pg) per embryo (Table 1). The amount
Oocyte microinjection Figure 6
Oocyte microinjection. The short hairpin (sh)RNAi microin-
jection of a the germinal vesicle (GV) stage bovine oocyte. 
(A) The oocyte has been localized and is subsequently micro-
injected with shRNAi molecules (B). The oocyte is being held 
by the holding pipette and microinjected by a pipette of 4 µm 
in diameter and beveled at 35°. Care was taken not to strip 
off the cumulus cells surrounding the GV oocytes and to 
avoid perforating the germinal vesicle during microinjection.BMC Developmental Biology 2007, 7:132 http://www.biomedcentral.com/1471-213X/7/132
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of p66Shc mRNA is even higher in arrested 2–4 cell
embryos collected at day-8 post-insemination, at 4.02 ±
0.21 × 10-5 pg per embryo (Table 1). These results, along
with the consensus that the major activation of embryonic
transcription occurs at the 8–16 cell stage in bovine
embryos [48,49], suggest that the increased levels of
p66Shc mRNA and protein in arrested embryos may be
due to an increase in p66Shc mRNA stability and/or pro-
tein stability through post-transcriptional or post-transla-
tional modifications. Recently, the small GTPase rac1 has
been shown to induce phosphorylation-dependent
increase in the stability of p66Shc in various somatic cell
lines [50]. Future experiments will elucidate whether the
increase in p66Shc in arrested embryos is due to de novo
transcription, increased transcript stability and/or protein
stability.
There was no increase in spontaneously cleaved oocytes
upon RNAi microinjection detected in this study, in con-
trast to the results obtained in the mouse [43,45]. Sponta-
neous oocyte cleavage induced by the microinjection
procedure itself, while occurring in some species such as
mouse [51], humans [52] and hamsters [53], does not
readily occur in the bovine [54]. In the absence of chemi-
cal activation, approximately 4% of injected bovine
oocytes cleaved [54], which is consistent with the results
presented in this study where 2.1 ± 2.0% of injected
oocytes spontaneously cleaved following microinjection.
Most spontaneously cleaved bovine oocytes exhibit devel-
opmental delay/arrest [55], suggesting that the reduction
in spontaneous cleaved oocytes in the microinjected
groups compared to non-injected controls (Fig. 4D) may
account for the reduction in embryo arrest. However,
there was also significant reduction in spontaneous
oocyte cleavage in the vehicle-microinjected group with-
out a concomitant reduction in the proportion of
embryos permanently arresting at the 2–4 cell stage. This
result further supports that the decrease in arrested
embryos observed for the p66Shc shRNAi microinjected
group was not due to a reduction in spontaneous oocyte
cleavage but to the knockdown in p66Shc levels.
P66Shc knock-out mice are viable, but the fertility of
p66Shc null females has not been reported [32]. In this
study, RNAi-mediated reduction in p66Shc mRNA and
protein significantly reduced the proportion of embryos
arrested at the 2–4 cell stage (0.9 ± 0.9%), but only 8.7 ±
1.4% developed to the blastocyst stage (Fig. 4B), suggest-
ing that escape from arrest leads to embryo demise by
other means at later developmental stages and that
p66Shc has a variety of functions during early embryo
development. The reduction in blastocyst yield might sug-
gest RNAi toxicity to the oocytes/embryos, but this is not
likely since histone H2a and p53 mRNA levels were
unchanged for both the 2-cell embryo and blastocyst
stages after p66Shc RNA interference. Any insult/toxicity
would greatly affect the expression of most genes
[3,56,57], rather than isolated individual loci. The use of
long (>30 nt) dsRNA molecules have been shown to trig-
ger a sequence non-specific interferon response [58],
however the use of short interfering and short hairpin
RNAi molecules in mammalian cells and embryos have
not shown any toxicity or interferon response [41,44,58].
The lack of alterations in p53 mRNA levels also suggest
that p53 is not affected by p66Shc mRNA down-regula-
tion, consistent with our previous observations, which
propose that embryo arrest and death are p53-independ-
ent events in early bovine embryos [2,12]. The levels of
p66Shc transcripts after a 54% p66Shc knockdown with
~12,000 shRNAi molecules in 35 hpi, 2–4 cell embryos
(0.46 ± 0.06 × 10-5  pg/embryo) is equivalent to the
amount of p66Shc mRNA normally observed in a devel-
oping bovine blastocyst (0.50 ± 0.07 × 10-5 pg) (Table 1),
suggesting that we were working in a physiological range
typically measured in blastocysts. At the blastocyst stage
no differences in p66Shc mRNA levels were observed
between the control, vehicle microinjected and p66Shc
RNAi microinjected groups (Fig. 2). This result indicates
that the RNAi molecules either induced only a temporary
effect on endogenous p66Shc levels, or that an optimal
concentration of p66Shc is necessary for continued devel-
opment.
Besides p66Shc's role in normal cell management of stress
and damage repair, p66Shc functions in regulating mito-
chondrial metabolism [59]. In the absence of p66Shc,
mouse embryonic fibroblasts and PC12 cells both exhibit
a reduction in mitochondrial oxidative phosphorylation
capacity, which was partially offset by increased levels of
aerobic glycolysis and lactate production [59]. This altered
mitochondria metabolism in p66Shc deficient cells is the
most likely explanation for the reduced blastocyst fre-
quencies observed for the p66Shc knockdown embryo
group. Quantitative assessment at timed stages of devel-
opment coupled with a titrated silencing of p66Shc under
culture conditions with varying oxygen levels and energy
sources will help clarify the metabolic role of this protein
during early embryo development.
p66Shc is an adaptor protein that is activated in response
to oxidative stress and appears to play a crucial role in
mediating cell death and cellular senescence [23,32].
Conversely, Trinei et al. (2002) showed that p66Shc is an
oxidative stress inducer, increasing reactive oxygen species
(ROS) production [28]. It is possible that the reduction in
permanently arrested 2–4 cell embryos in the p66Shc shR-
NAi injected group is due to a decline in mitochondrial
ROS production and an increase in stress resistance.
Recent studies have shown that oxidative stress-activated
p66Shc can translocate into the mitochondrial intermem-BMC Developmental Biology 2007, 7:132 http://www.biomedcentral.com/1471-213X/7/132
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brane space where it interacts with reduced cytochrome c
to produce H2O2 which promotes the opening of permea-
bility transition pores allowing for the release of ROS and
other constituents into the cytosol [29,60,61]. The locali-
zation of p66Shc protein throughout and as distinct foci
within the cytoplasm of bovine embryos corroborates
with this data. ROS are involved in the redox-dependent
regulation of various cellular functions, including energy
metabolism and the response to stress or growth signals
[62]. Our previous research demonstrated that elevated
oxygen tensions increase the levels of p66Shc, intracellu-
lar ROS and oxidative damage in bovine fibroblasts and
embryos [15,23], supporting other work that shows that
oxidative stress mediates p66Shc's function
[28,61,63,64]. Interestingly, embryos injected with the
high dose (~24,000) of p66Shc shRNAi molecules
appeared to cleave faster than those injected with the low
does (~12,000) of p66Shc RNAi hairpin molecules (data
not shown), supporting p66Shc's other known role in
antagonizing mitogenic signalling [65].
Embryo arrest and continued embryo development may
therefore be regulated, in part, by the translocation of
p66Shc into the inter-mitochondrial space where it con-
trols trans-membrane potential altering mitochondrial
metabolism and/or generating and releasing ROS into the
cytosol causing cellular damage that triggers permanent
cell cycle arrest at a developmental stage (2–4 cell
embryo) that is in an anti-apoptosis state [1] or apoptosis
at other developmental stages. p66Shc has been shown to
regulate redox-dependent inactivation of members from
the forkhead transcription factor family triggering their
translocation from the nucleus to the cytosol [64]. Fork-
head transcription factors have been reported to regulate
the expression of anti-apoptosis genes and several antioxi-
dant enzymes, including superoxide dismutase (SOD)
and catalase [64,66,67]. The nuclear and peri-nuclear
localization of p66Shc observed in this study and else-
where [68] may account for this extra-mitochondrial role
for p66Shc. RNAi-mediated knockdown of p66Shc in
embryos already deemed arrested and in embryos at later
developmental stages will reveal the developmental
capacity of arrested embryos and may uncover the aetiol-
ogy of the permanently arrest state and other p66Shc func-
tion(s) during later stages of early embryo development.
Finally, there is now supporting evidence that telomere-
driven senescence is triggered by mitochondrial produc-
tion of ROS [69,70]. ROS-mediated disruption of the tel-
omere structure may explain the high rates of
developmental arrest of in vitro produced embryos [17].
Preliminary evidence in our lab detecting phosphorylated
histone γ-H2A.X foci in arrested 2–4 cell embryos but not
in proliferating 2–4 cell embryos support this possibility
since phosphorylation of histone H2A.X appears to facili-
tate the formation of DNA damage foci around uncapped
telomeres [71]. Based on the immunolocalization studies
it is tempting to speculate that p66Shc may be involved in
a cycling cascade of events that triggers and maintains per-
manent embryo arrest through a ROS-mediated and
response pathway that permanently maintains a telomeric
DNA damage state.
Conclusion
In conclusion, using the post-transcriptional gene silenc-
ing approach of RNA interference by microinjecting short
hairpin RNAi molecules into bovine oocytes/embryos, we
were able to selectively diminish the levels of p66Shc and
correlated this knockdown with a significant reduction in
the incidence of 2–4 cell embryo arrest and with a signifi-
cant decrease in embryo development to the blastocyst
stage. These apparent contradictory roles for p66Shc in
both permanent embryo arrest and developmental com-
petence implies that p66Shc functions must be tightly reg-
ulated. Escape from permanent cell cycle arrest may
alleviate some cases of age-related infertility, or at least
provide a less controversial source of embryonic stem cells
from arrested embryos original deemed as non-viable,
biological waste.
Methods
Plasmid preparation and cells transformation
Two DNA oligonucleotides were synthesized at the
Guelph Molecular Supercentre (Guelph, ON, Canada). A
positive strand containing 19 nucleotides specific to the
p66Shc mRNA bovine sequence, a loop of nine non-com-
plementary nucleotides and the reverse complementary
sequence of the 19 nucleotides specific for the bovine
p66Shc mRNA, which incorporates the BamH1 restriction
site at the 5' end. The second oligonucleotide synthesized
consists of a negative strand reverse complementary to the
positive one, without the BamH1 site, but incorporating
at its 5' end a HindIII restriction site (Fig. 7). The 19-
nucleotide p66Shc target sequence was determined using
the computer software oligoengine™ (OligoEngine, Inc.,
Seattle, WA) and showed no homology with any other
known gene following BLAST search. The bovine
sequence used for the oligo design was a segment of 336
bp obtained by PCR using primers specific for the human
p66Shc sequence (Genbank number: U73377) and previ-
ously shown to specifically amplify bovine p66Shc [2].
The synthesized oligos were annealed in a concentration
of 1 µg/µl in DNA Annealing solution (Ambion Inc., Aus-
tin, TX), by denaturating them at 90°C for 3 minutes, fol-
lowed by an incubation step at 37°C for 1 hour. The
annealed oligos were then ligated with T4 ligase (New
England Biolabs, Beverly, MA) into a pSUPER plasmid
(OligoEngine, Inc.), 8 bp downstream of the T7 promoter
where the H1 region of the plasmid had previously been
removed by HindIII and SacI enzyme digestion. The pSU-BMC Developmental Biology 2007, 7:132 http://www.biomedcentral.com/1471-213X/7/132
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PER-p66Shc hairpin RNAi plasmid was purified by QIA
spin Maxiprep kit (QIAGEN Inc., Mississauga, ON, Can-
ada) following the manufacturer's instructions and
sequenced by Guelph Molecular Supercentre (Guelph,
ON, Canada) to assure proper insertion of the designed
oligonucleotides.
Generation of p66Shc short hairpin shRNAi molecule by 
T7 in vitro transcription
The pSUPER-p66Shc short hairpin RNAi plasmid was lin-
earized by HindIII digestion and the 3' overhang was con-
verted into a blunt end by T4 polymerase (New England
Biolabs). A total of 3 µg of the linearized plasmid was
incubated for 2 hours at 37°C with a mixture containing:
transcription buffer, 100 U of ribonuclease inhibitor, 100
mM of rNTP mix and 90 Units of T7 RNA polymerase in a
final volume of 50 µl with deionized (nuclease free) water
(T7 Transcription Kit, MBI Fermentas). The plasmid DNA
template was digested by incubating at 37°C for 30 min-
utes with 3 µl of DNase I in DNase buffer (DNA-free™,
Ambion Inc.), and the enzyme was inactivated by the
addition of 5 µl of DNase Inactivation Reagent. The RNA
product was isolated, using RNeasy® Mini Kit (QIAGEN
Inc.), following the manufacturer's instructions. The RNA
was quantified by spectrophotometric analysis and stored
at -80°C until further used. The RNA size was confirmed
by running an aliquot on a 2% agarose gel together with
100 bp ladder (Invitrogen, Burlington, ON, Canada).
Oocyte microinjection, oocyte maturation and embryo 
culture
Bovine ovaries were obtained from a local slaughterhouse
(Better Beef Ltd., Guelph, ON, Canada) and cumulus-
oocyte complexes (COCs) were collected by follicular
aspiration into HEPES-buffered Ham's F-10 (Sigma-
Aldrich Canada, Oakville, ON, Canada) supplemented
with 2% steer serum (Cansera, Rexdale, ON, Canada), as
previously described [2]. Oocytes were randomly divided
into three groups: oocytes were matured, fertilized and
cultured without being microinjected (control), oocytes
were either microinjected with the vehicle alone (microin-
jection control), or with 12,000 or 24,000 molecules of
p66Shc shRNAi, followed by fertilization and culture. A
Narishige microinjector (Narishige, McHenry, IL) was
used to microinject a volume of 0.25 picolitres of RNase-
free water with or without p66Shc shRNAi molecules. The
holding pipette had an outer diameter of 100 µm with an
inner diameter of 30–40 µm (larger than usual to avoid
P66Shc short hairpin (sh)RNAi molecule sequence Figure 7
P66Shc short hairpin (sh)RNAi molecule sequence. The positive strand (A) was designed with a BamH1 site at the 5' end fol-
lowed by the 19 nucleotide specific for bovine p66Shc (underlined), a loop of 9 non-complementary nucleotides and the 
reverse complementary sequence of the 19 nucleotides specific for bovine p66Shc (underlined). The negative strand (B) con-
sists of the reverse complementary to the positive one, without the BamH1 site, but with a HindIII restriction site at its 5' end. 
(C) The represented shRNAi structure that is formed within the oocyte/embryo upon microinjection.BMC Developmental Biology 2007, 7:132 http://www.biomedcentral.com/1471-213X/7/132
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stripping the cumulus cells off). The injection pipette was
4 µm in diameter and beveled at 35° (Sunpipettes-ICSI,
IVFonline, Guilford, CT). The microinjector controlled
the injection pipette whereas the holding pipette was con-
trolled manually (Fig. 6). COCs awaiting microinjection
were washed three times and kept in in vitro culture (IVC)
medium, consisting of TCM-199 supplemented with 0.2
M sodium pyruvate, 0.6% penicillin-streptomycin, and
0.1% Poly Vinyl Alcohol (PVA) (Sigma-Aldrich) medium,
at 38.5°C in a humidified atmosphere. Microinjection
was carried out in 60 µl drops of HEPES-buffered Ham's
F-10 (Sigma-Aldrich) supplemented with 2% steer serum
(Cansera) under silicone oil (Paisley Products, Scarbor-
ough, ON, Canada). A total of 10–15 oocytes were indi-
vidually injected at a time to reduce exposure to sub-
optimal conditions. Within one hour 100–120 COCs
were microinjected. Due to the relatively "harsh" microin-
jection procedures some oocytes ruptured or fragmented
immediately following injection and were removed from
the study. Triplicate groups of 80–100 of intact microin-
jected/non-injected oocytes per treatment group were
then matured, fertilized, and the embryos cultured follow-
ing the protocol previously described in detail [2]. In
brief, COCs were matured in 80 µl drops of maturation
medium with the addition of 0.1 µg/ml of Follicle Stimu-
lating Hormone (FSH), 1 µg/ml of Luteinizing Hormone
(LH) and 1 µg/ml of estradiol (NIH, Washington DC)
under silicon oil for 22 hours at 38.5°C in a humidified
atmosphere of 5% CO2  in air. Matured oocytes were
washed as described previously [72]. Approximately 30
COCs were placed into each 100 µl drop of fertilization
medium, IVF-TALP (Hepes/Sperm TALP, supplemented
with 20 µg/ml heparin (Sigma-Aldrich) under oil. Frozen-
thawed bovine semen (Gencor, Guelph, ON, Canada)
was prepared by swim-up technique. COCs were co-incu-
bated with sperm at a final concentration of approxi-
mately 1 × 106 motile sperm/ml for 16 to 18 hours at
38.5°C in a humidified atmosphere of 5% CO2 in air. Fol-
lowing co-incubation, the remaining cumulus cells were
removed by gentle vortexing. Presumptive zygotes were
transferred to 50 µl drops of IVC medium under oil.
Groups of 25–30 presumptive zygotes were co-cultured
with approximately 20 bovine oviductal epithelial cell
vesicles for up to 9 days. To sustain development through
to the blastocyst stage, 20 µl of fresh IVC medium was
added to each drop after 48 hours of culture.
Total RNA extraction
Total RNA was extracted from each pool of embryos using
QIA Shredder™ and RNeasy® Mini Kit (QIAGEN Inc.),
according to the manufacturer's instructions. The RNA
was co-precipitated using 2 µl of SeeDNA (Amersham Bio-
sciences Corp., Baie d'Urfé, QC, Canada) as a carrier by
the addition of 0.1 × volume of 3 M sodium acetate (pH
5.2) (Amersham Biosciences Corp.) and 2 × volume of
ice-cold absolute ethanol. The RNA pellet was air-dried
and resuspended in 8 µl of RNase-free water. Samples
then underwent DNase treatment, according to the man-
ufacturer's instructions (DNA-free™, Ambion Inc.). Fol-
lowing DNase treatment, samples were reverse
transcribed immediately or stored at -80°C for future use.
Reverse Transcription (RT)
RT reactions were performed on the RNA extracted from
pools of oocytes/embryos using 500 ng of oligo (dT)12–18
and Superscript II (Invitrogen) reverse transcriptase,
according to the following protocol. The oligo (dT)12–18
was first added to the RNA samples and allowed to anneal
by denaturing the secondary structures at 70°C for 2 min,
then a mixture of 4 µl RT buffer, 1 µl of 0.1 M dithiothre-
itol, 1 µl of 10 mM dNTP mix, 0.5 µl of RNAsin (40 U/µl)
(Promega, Madison, WI) and 1 µl of Superscript II (200
U/µl) was added and the reaction was incubated at 42°C
for 1 hour, followed by a denaturing step at 70°C for 30
min. To amplify p66Shc, p53 and H2a cDNAs the primers
(Table 2) that have been previously optimized for the
bovine species were used [2].
Real Time RT-PCR
The PCRs were conducted in a Light Cycler apparatus
(Roche Molecular Biochemicals, Laval, QC, Canada) and
products were detected with SYBR Green (FastStart Master
SYBR Green I mix, Roche Molecular Biochemicals). Prior
to the quantification, optimization procedures were per-
formed by running PCRs with or without the purified
template to identify the melting temperatures of the
primer dimers and the specific product. To measure the
level of mRNA in the samples, the fluorescence values
were taken at the temperature associated with the begin-
Table 2: Oligonucleotide Primers used for Real Time amplification
Gene GenBank accession number Sequence Product size (bp) Species
p66Shc U73377 5'-GTGAGGTCTGGGGAGAAGC-3'
5'-GGTTCGGACAAAGGATCACC-3'
336 Homo sapiens
H2a U62674 5'-GTCGTGGCAAGCAAGGAG-3'
5'-GATCTCGGCCGTTAGGTACTC-3'
374 Mus musculus
p53 U74486 5'-CTCAGTCCTCTGCCATACTA-3'
5'-GGATCCAGGATAAGGTGAGC-3'
364 Bos IndicusBMC Developmental Biology 2007, 7:132 http://www.biomedcentral.com/1471-213X/7/132
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ning of the peak for the specific product, 84°C for p53,
86°C for p66Shc and 88°C for H2a. For each quantifica-
tion a 1 µl aliquot of the RT reaction was used. The stand-
ard curve was established using the DNA template in six
serial dilutions ranging from 1 × 102 pg to 1 × 10-4 pg. The
amplification program was as follows: Preincubation for
FastStart polymerase activation at 95°C for 10 minutes,
followed by 40 amplification cycles of denaturation at
95°C (20°C/sec), annealing for 5 sec (20°C/sec), elonga-
tion at 72°C and acquisition of fluorescence for 5 sec
(20°C/sec). After the end of the last cycle, starting the flu-
orescence acquisition at 72°C and taking measurements
every 0.1°C until 95°C was reached generated the melting
curve. Amplification was performed on the histone H2a
gene as an endogenous standard to assure equal RT effi-
ciency and for p66Shc knockdown specificity.
Whole-mount indirect immunofluorescence and confocal 
microscopy of p66Shc
In order to verify the knockdown efficiency at the protein
level, ~12,000 (low group) and ~24,000 (high group)
shRNAi molecules were injected at the zygote stage, 18 h
post co-culture with sperm or 1 hpi. Early 2–4 cell staged
bovine embryos were collected and processed at 35 hpi
for application of whole-mount immunofluorescence as
described previously [73,74]. Sixty embryos were injected
for each group over three repetitions and about 30
embryos were assessed for p66Shc immunoflurescence
intensity from each repetition. Embryo pools were fixed in
2% paraformaldehyde in PBS, washed in PBS and then
either processed immediately for whole-mount indirect
immunofluorescence or stored at 4°C in Embryo Storage
Buffer (1 × PBS + 0.9% sodium azide) for up to 3 weeks.
Fixed embryos were permeabilized and blocked concur-
rently by room temperature incubation in Embryo Block-
ing Buffer (0.01% Triton X-100 + 5% Normal Donkey
Serum in 1 × PBS) for 1 hour followed by one wash in
fresh 1 × PBS for 30 minutes at 37°C. Embryos were incu-
bated with primary antisera (Rabbit anti-human p66Shc;
Catalog #AB3824, Millipore) at non-saturating condi-
tions using a 1:100 dilution in Antibody Dilution/Wash
Buffer (ADB: 0.005% Triton X-100 + 1% Normal Donkey
Serum in 1 × PBS) at 4°C overnight. Embryos were then
washed 3 times for 20–30 minutes in ADB at 37°C and
incubated with FITC-conjugated secondary antibodies
(Jackson ImmunoResearch Laboratories Inc., West Grove,
PA, USA) at 1:200 dilution in ADB overnight at 4°C. To
visualize F-actin localization and to stain nuclear DNA,
the first 30 minute wash in ADB following secondary anti-
body incubation embryos were treated with rhodamine-
conjugated phalloidin (5 µg/ml; 1:20, Sigma-Aldrich Can-
ada Ltd., Oakville, ON, Canada) and DAPI (1 mg/ml;
1:2000, Sigma-Aldrich Canada Ltd., Oakville, ON, Can-
ada) for 30 minutes at 37°C followed by 2 washes for 2
hours each at 37°C. Fully processed embryos were
mounted onto glass slides in a drop of FluoroGuard™
Anti-Fade Reagent (BioRad Laboratories Canada Ltd.,
Mississauga, ON, Canada). Immunofluorescence imaging
was carried out by confocal microscopy using an Olympus
Fluoview Laser Scanning Confocal system on an IX81
inverted microscope equipped with a computer running
the Olympus Fluoview software (v. 4.3).
Image analysis and quantification of immunofluorescence 
intensity
To quantify immunofluorescence results we employed the
method developed and reported by [75,76]. All micro-
scope and image capture settings remained constant dur-
ing the digital capture of confocal micrographs between
embryos and between treatment groups. Acquired micro-
graphs were saved in TIFF image format and processed
using Adobe Photoshop CS2 (Adobe Systems Inc., San
Jose, CA, USA), for recognition, selection and separation
of the desired chromogen signal. Quantitative analysis
began by separation of the green image channel represent-
ing FITC fluorescence of p66Shc protein from the red
(representing Rhodamine-phalloidin-labelled F-actin)
and blue (representing DAPI-stained nuclei) channels.
The green channel image was converted to "Grayscale",
discarding the other two color channels to ensure the sig-
nal remaining represented only FITC fluorescence. The
overall luminance of each pixel in the converted image
corresponded to the intensity of FITC fluorescence. Each
converted micrograph was then inverted so that grey and
black pixels represented areas of FITC immunofluores-
cence on a white background and saved as a new TIFF
image file for Scion Image analysis.
The Scion Image program, Version 4.0.3.2 (Scion Corpo-
ration, Frederick, MD, USA), is a freely distributed com-
mercial software program that mimics the performance of
NIH Image program for quantification of the chromogen
signal strength [75]. The greyscale inverted micrographs
were opened in Scion Image and following the methods
of [75], the mean density of the chromogen signal
strength (SS) of each image was measured and recorded.
The average SS from at least three micrographs represent-
ing no primary antibody controls was subtracted from the
SS values of the measured images from each treatment
group to produce an adjusted relative SS value. Relative
signal strength (RSS) values represented in pixels were
plotted on the graph.
Assessment of cleavage, blastocyst and arrest frequencies
Developmental potential was assessed by evaluating the
frequency of embryos cleaving at day-2 post insemination
(p.i.), and percentage of those reaching the blastocyst
stage at day 8–9 p.i. Embryos were considered "arrested"
when still appearing as "morphologically normal" 2–4
cell embryos at day 8 post insemination (Fig. 1). The fre-BMC Developmental Biology 2007, 7:132 http://www.biomedcentral.com/1471-213X/7/132
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quencies of blastocyst formation and embryo arrest were
calculated as a proportion of the total number of cleaved
embryos. The proportion of spontaneously cleaved
oocytes was evaluated in each IVF experiment using a
group of oocytes (10 to 15 oocytes per experiment)
matured and cultured, omitting the fertilization step. The
spontaneous cleavage rate was calculated at 35 hpi as the
number of oocytes cleaving in absence of sperm over the
total number of oocytes in each group.
Statistical analysis
Statistical analysis was performed using one-way ANOVA
and Fisher LSD multiple comparison test. The non-para-
metrical equivalent test (Kruskal-Wallis) was used when
samples did not meet the assumption of normal distribu-
tion or homogeneity of variance. The results are presented
as the means ± SEM from three independent experiments.
Data were analyzed by MINITAB™ software or SPSS®, Ver-
sion 14.0 (SPSS Inc., Chicago, IL, USA) and means were
considered significantly different when P < 0.05 using the
least-significant-difference test.
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